Movement Alert|UBTECH Falls 3.76% in Regular Trading, U1 Bionic Robot Draws Widespread Criticism as H-Share Full Circulation Adds Selling Pressure Concerns

Market Focus07-06

On July 6, UBTECH fell 3.76% in regular trading, trading at 102.7 HKD/share, with turnover of 81.82 million HKD. Multiple negative catalysts converged over the weekend, pressuring the stock at the open of the new trading week.

The company's newly launched UWORLD U1 ultra-bionic humanoid robot series faced a wave of online criticism over the weekend. Users and media widely noted significant discrepancies between promotional CG renders and actual product performance, citing mechanical gait, stiff facial expressions, limited 2-4 hour battery life, and lack of practical household functions despite prices ranging from 119,800 to 990,000 yuan. Reports indicated some pre-order holders expressed intent to cancel, undermining confidence in the 13,000+ unit order backlog announced at the June 30 launch event.

Compounding the sentiment, the company disclosed on July 3 that it received a filing notice from the CSRC for H-share full circulation involving 5.4539 million domestic shares to be converted into tradeable H-shares. While the scale is limited, the incremental supply expectation weighed on short-term market sentiment.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment